BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 38802532)

  • 1. Novel gene-specific Bayesian Gaussian mixture model to predict the missense variants pathogenicity of Sanfilippo syndrome.
    Mohammed EEA; Fayez AG; Abdelfattah NM; Fateen E
    Sci Rep; 2024 May; 14(1):12148. PubMed ID: 38802532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utilizing ExAC to assess the hidden contribution of variants of unknown significance to Sanfilippo Type B incidence.
    Clark WT; Yu GK; Aoyagi-Scharber M; LeBowitz JH
    PLoS One; 2018; 13(7):e0200008. PubMed ID: 29979746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Postnatal and prenatal diagnosis of mucopolysaccharidosis type III (Sanfilippo syndrome)].
    Zhang WM; Shi HP; Meng Y; Li BT; Qiu ZQ; Liu JT
    Zhonghua Er Ke Za Zhi; 2008 Jun; 46(6):407-10. PubMed ID: 19099774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mucopolysaccharidosis IIIB and mild skeletal anomalies: coexistence of NAGLU and CYP26B1 missense variations in the same patient in a Chinese family.
    Li J; Xie H; Jiang Y
    BMC Med Genet; 2018 Apr; 19(1):51. PubMed ID: 29606097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. REVEL: An Ensemble Method for Predicting the Pathogenicity of Rare Missense Variants.
    Ioannidis NM; Rothstein JH; Pejaver V; Middha S; McDonnell SK; Baheti S; Musolf A; Li Q; Holzinger E; Karyadi D; Cannon-Albright LA; Teerlink CC; Stanford JL; Isaacs WB; Xu J; Cooney KA; Lange EM; Schleutker J; Carpten JD; Powell IJ; Cussenot O; Cancel-Tassin G; Giles GG; MacInnis RJ; Maier C; Hsieh CL; Wiklund F; Catalona WJ; Foulkes WD; Mandal D; Eeles RA; Kote-Jarai Z; Bustamante CD; Schaid DJ; Hastie T; Ostrander EA; Bailey-Wilson JE; Radivojac P; Thibodeau SN; Whittemore AS; Sieh W
    Am J Hum Genet; 2016 Oct; 99(4):877-885. PubMed ID: 27666373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update of the spectrum of mucopolysaccharidoses type III in Tunisia: identification of three novel mutations and in silico structural analysis of the missense mutations.
    Ouesleti S; Coutinho MF; Ribeiro I; Miled A; Mosbahi DS; Alves S
    World J Pediatr; 2017 Aug; 13(4):374-380. PubMed ID: 28101780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of predicted enzymatic activity of α-N-acetylglucosaminidase variants of unknown significance for CAGI 2016.
    Clark WT; Kasak L; Bakolitsa C; Hu Z; Andreoletti G; Babbi G; Bromberg Y; Casadio R; Dunbrack R; Folkman L; Ford CT; Jones D; Katsonis P; Kundu K; Lichtarge O; Martelli PL; Mooney SD; Nodzak C; Pal LR; Radivojac P; Savojardo C; Shi X; Zhou Y; Uppal A; Xu Q; Yin Y; Pejaver V; Wang M; Wei L; Moult J; Yu GK; Brenner SE; LeBowitz JH
    Hum Mutat; 2019 Sep; 40(9):1519-1529. PubMed ID: 31342580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of two induced pluripotent stem cells lines from a Mucopolysaccharydosis IIIB (MPSIIIB) patient.
    Vallejo-Diez S; Fleischer A; Martín-Fernández JM; Sánchez-Gilabert A; Bachiller D
    Stem Cell Res; 2018 Dec; 33():180-184. PubMed ID: 30408744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ensemble variant interpretation methods to predict enzyme activity and assign pathogenicity in the CAGI4 NAGLU (Human N-acetyl-glucosaminidase) and UBE2I (Human SUMO-ligase) challenges.
    Yin Y; Kundu K; Pal LR; Moult J
    Hum Mutat; 2017 Sep; 38(9):1109-1122. PubMed ID: 28544272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Machine learning classifier for identification of damaging missense mutations exclusive to human mitochondrial DNA-encoded polypeptides.
    Martín-Navarro A; Gaudioso-Simón A; Álvarez-Jarreta J; Montoya J; Mayordomo E; Ruiz-Pesini E
    BMC Bioinformatics; 2017 Mar; 18(1):158. PubMed ID: 28270093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic features of patients with MPS type IIIB: Description of five pathogenic gene variations.
    Nasir Shalal M; Aminzadeh M; Saberi A; Azizi Malmiri R; Aminzadeh R; Ghandil P
    Gene; 2024 Jun; 913():148354. PubMed ID: 38492611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Untypically mild phenotype of a patient suffering from Sanfilippo syndrome B with the c.638C>T/c.889C>T (p.Pro213Leu/p.Arg297Ter) mutations in the NAGLU gene.
    Pierzynowska K; Mański A; Limanówka M; Wierzba J; Gaffke L; Anikiej P; Węgrzyn G
    Mol Genet Genomic Med; 2020 Sep; 8(9):e1356. PubMed ID: 32578945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphic variants (p.Ser141Ser and p.Arg737Gly) at the NAGLU gene are really indicative of pseudodeficiency alleles?
    Rojas Malaga D; Leistner-Segal S; Brusius-Facchin AC
    Ital J Pediatr; 2019 May; 45(1):60. PubMed ID: 31088528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sanfilippo type B syndrome: five patients with an R565P homozygous mutation in the alpha-N-acetylglucosaminidase gene from the Okinawa islands in Japan.
    Chinen Y; Tohma T; Izumikawa Y; Uehara H; Ohta T
    J Hum Genet; 2005; 50(7):357-359. PubMed ID: 15933803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of the Mutational Landscape of the Sodium/Iodide Symporter in Congenital Hypothyroidism.
    Martín M; Nicola JP
    Thyroid; 2021 Dec; 31(12):1776-1785. PubMed ID: 34514854
    [No Abstract]   [Full Text] [Related]  

  • 16. Performance of in silico prediction tools for the classification of rare BRCA1/2 missense variants in clinical diagnostics.
    Ernst C; Hahnen E; Engel C; Nothnagel M; Weber J; Schmutzler RK; Hauke J
    BMC Med Genomics; 2018 Mar; 11(1):35. PubMed ID: 29580235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Predictive
    Pshennikova VG; Barashkov NA; Romanov GP; Teryutin FM; Solov'ev AV; Gotovtsev NN; Nikanorova AA; Nakhodkin SS; Sazonov NN; Morozov IV; Bondar AA; Dzhemileva LU; Khusnutdinova EK; Posukh OL; Fedorova SA
    ScientificWorldJournal; 2019; 2019():5198931. PubMed ID: 31015822
    [No Abstract]   [Full Text] [Related]  

  • 18. Klüver-Bucy syndrome associated with a recessive variant in HGSNAT in two siblings with Mucopolysaccharidosis type IIIC (Sanfilippo C).
    Hu H; Hübner C; Lukacs Z; Musante L; Gill E; Wienker TF; Ropers HH; Knierim E; Schuelke M
    Eur J Hum Genet; 2017 Feb; 25(2):253-256. PubMed ID: 27827379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accuracy of a machine learning method based on structural and locational information from AlphaFold2 for predicting the pathogenicity of TARDBP and FUS gene variants in ALS.
    Hatano Y; Ishihara T; Onodera O
    BMC Bioinformatics; 2023 May; 24(1):206. PubMed ID: 37208601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular genetics of mucopolysaccharidosis type IIIA and IIIB: Diagnostic, clinical, and biological implications.
    Yogalingam G; Hopwood JJ
    Hum Mutat; 2001 Oct; 18(4):264-81. PubMed ID: 11668611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.